ADAP stock price (quote)
$1.14 -6.56% Thursday, 5th Dec 2019
Close price at the end of the last trading day (Thursday, 5th Dec 2019) of the ADAP stock was $1.14. This is 6.56% less than the trading day before Wednesday, 4th Dec 2019.
During the day the stock fluctuated 13.89% from a day low at $1.08 to a day high of $1.23.
Quick summary:
- 30 day high of the ADAP stock price was $1.29 and low was $0.71.
- 90 day high was $2.25 and low was $0.71.
- 52 week high for Adaptimmune Therapeutics plc - $6.31 and low - $0.71.
VOLUME
Buy
TREND
Sell
MV LONG
Buy
MV SHORT
Buy
PIVOT
Sell
MACD
Buy
Historical Adaptimmune Therapeutics plc prices
| Date | Open | High | Low | Close | Volume |
| 2019-12-05 | $1.23 | $1.23 | $1.08 | $1.14 | 518218 |
| 2019-12-04 | $1.26 | $1.29 | $1.17 | $1.22 | 477181 |
| 2019-12-03 | $1.29 | $1.29 | $1.17 | $1.26 | 604731 |
| 2019-12-02 | $1.16 | $1.21 | $1.04 | $1.19 | 640040 |
| 2019-11-29 | $0.97 | $1.17 | $0.96 | $1.17 | 339131 |
| 2019-11-27 | $0.91 | $0.96 | $0.86 | $0.96 | 132410 |
| 2019-11-26 | $0.87 | $0.92 | $0.85 | $0.90 | 220361 |
| 2019-11-25 | $0.84 | $0.97 | $0.84 | $0.88 | 579940 |
| 2019-11-22 | $0.83 | $0.88 | $0.79 | $0.84 | 222711 |
| 2019-11-21 | $0.89 | $0.94 | $0.81 | $0.82 | 327958 |
| 2019-11-20 | $0.80 | $0.91 | $0.75 | $0.87 | 592068 |
| 2019-11-19 | $0.74 | $0.82 | $0.74 | $0.81 | 421654 |
| 2019-11-18 | $0.76 | $0.80 | $0.73 | $0.76 | 207694 |
| 2019-11-15 | $0.82 | $0.85 | $0.71 | $0.73 | 340783 |
| 2019-11-14 | $0.85 | $0.90 | $0.78 | $0.80 | 398377 |
| 2019-11-13 | $0.86 | $0.91 | $0.80 | $0.85 | 140335 |
| 2019-11-12 | $0.85 | $0.92 | $0.82 | $0.86 | 457966 |
| 2019-11-11 | $0.90 | $0.95 | $0.80 | $0.82 | 386103 |
| 2019-11-08 | $0.90 | $0.97 | $0.85 | $0.88 | 266224 |
| 2019-11-07 | $0.92 | $0.97 | $0.89 | $0.90 | 213907 |
| 2019-11-06 | $0.95 | $1.04 | $0.90 | $0.92 | 557799 |
| 2019-11-05 | $1.17 | $1.17 | $1.08 | $1.10 | 406592 |
| 2019-11-04 | $1.00 | $1.10 | $0.98 | $1.10 | 452567 |
| 2019-11-01 | $0.88 | $0.97 | $0.88 | $0.96 | 291112 |
| 2019-10-31 | $0.88 | $0.94 | $0.86 | $0.88 | 257229 |
| 2019-10-30 | $0.89 | $0.90 | $0.86 | $0.88 | 245660 |
| 2019-10-29 | $0.88 | $0.90 | $0.87 | $0.89 | 148377 |
| 2019-10-28 | $0.90 | $0.90 | $0.87 | $0.90 | 139541 |
| 2019-10-25 | $0.89 | $0.90 | $0.83 | $0.89 | 356158 |
| 2019-10-24 | $1.00 | $1.00 | $0.86 | $0.89 | 317841 |
| 2019-10-23 | $1.00 | $1.01 | $0.98 | $0.99 | 107835 |
| 2019-10-22 | $0.99 | $1.01 | $0.98 | $1.00 | 180273 |
| 2019-10-21 | $0.99 | $1.02 | $0.97 | $0.99 | 155962 |
| 2019-10-18 | $1.07 | $1.10 | $0.95 | $0.97 | 1076963 |
| 2019-10-17 | $1.02 | $1.07 | $0.97 | $1.00 | 255765 |
| 2019-10-16 | $1.03 | $1.05 | $0.98 | $1.00 | 202466 |
| 2019-10-15 | $1.04 | $1.09 | $1.00 | $1.02 | 264268 |
| 2019-10-14 | $1.06 | $1.11 | $1.02 | $1.02 | 261822 |
| 2019-10-11 | $1.09 | $1.17 | $1.06 | $1.06 | 1095932 |
| 2019-10-10 | $1.06 | $1.13 | $1.02 | $1.08 | 395800 |
| 2019-10-09 | $1.05 | $1.14 | $1.01 | $1.08 | 358711 |
| 2019-10-08 | $1.06 | $1.12 | $0.96 | $1.01 | 1264633 |
| 2019-10-07 | $1.24 | $1.25 | $1.07 | $1.10 | 504147 |
| 2019-10-04 | $1.26 | $1.30 | $1.20 | $1.22 | 211462 |
| 2019-10-03 | $1.37 | $1.40 | $1.28 | $1.28 | 237798 |
| 2019-10-02 | $1.40 | $1.45 | $1.32 | $1.40 | 150936 |
| 2019-10-01 | $1.53 | $1.60 | $1.40 | $1.43 | 274469 |
| 2019-09-30 | $1.50 | $1.57 | $1.45 | $1.51 | 206554 |
| 2019-09-27 | $1.57 | $1.70 | $1.42 | $1.47 | 429083 |
| 2019-09-26 | $1.67 | $1.72 | $1.56 | $1.56 | 468806 |
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Latest ADAP News
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
12:08pm, Friday, 15'th Nov 2019
Cowen Reaffirms “Buy” Rating for Adaptimmune Therapeutics (NASDAQ:ADAP)
11:15pm, Monday, 11'th Nov 2019
Is Adaptimmune Therapeutics plc (ADAP) Is Burning These Hedge Funds
05:52pm, Thursday, 31'st Oct 2019
The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug
11:12am, Friday, 25'th Oct 2019
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
11:58am, Wednesday, 09'th Oct 2019
The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering
11:32am, Friday, 04'th Oct 2019
Adaptimmune (ADAP) Gets Orphan Drug Status for T-cell Therapy
08:01am, Tuesday, 10'th Sep 2019Proudly made at
